On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

A bill before the Arkansas legislature would prevent pharmacy benefit managers (PBMs) or insurance companies from obtaining ...

Pharmacy benefit managers actually "play a vital role in holding" sometimes-inflated prices down, said UHG CEO Andrew Witty ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

Newer entrants to the pharmacy benefit management market will continue to face stiff competition in 2025 as they seek more ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...